CanBas Co (TSE:4575) Total Liabilities : 円110.73 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is CanBas Co Total Liabilities?

CanBas Co's Total Liabilities for the quarter that ended in Dec. 2024 was 円110.73 Mil.

CanBas Co's quarterly Total Liabilities declined from Mar. 2024 (円99.13 Mil) to Jun. 2024 (円91.99 Mil) but then increased from Jun. 2024 (円91.99 Mil) to Dec. 2024 (円110.73 Mil).

CanBas Co's annual Total Liabilities declined from Jun. 2022 (円540.02 Mil) to Jun. 2023 (円153.85 Mil) and declined from Jun. 2023 (円153.85 Mil) to Jun. 2024 (円91.99 Mil).

CanBas Co Total Liabilities Historical Data

The historical data trend for CanBas Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanBas Co Total Liabilities Chart

CanBas Co Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Liabilities

Get a 7-Day Free Trial

1,026.38

857.64

540.02

153.85

91.99

CanBas Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															121.88	121.14	99.13	91.99	110.73

CanBas Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CanBas Co's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	91.988	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	91.99

Total Liabilities	=	Total Assets (A: Jun. 2024 )	-	Total Equity (A: Jun. 2024 )
	=	2432.855	-	2340.867
	=	91.99

CanBas Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	110.735	+	(0	+	-0.0010000000000048
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	110.73

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	3131.909	-	3021.175
	=	110.73

CanBas Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of CanBas Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CanBas Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CanBas Co Ltd (TSE:4575) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-2-1 Otemachi, Numazu, Shizuoka, JPN, 410-0891

Website

http://www.canbas.co.jp

CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.

CanBas Co Headlines

No Headlines